{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:34:18Z","timestamp":1780630458771,"version":"3.54.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"11-12","license":[{"start":{"date-parts":[[2010,9,14]],"date-time":"2010-09-14T00:00:00Z","timestamp":1284422400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunogenetics"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s00251-010-0474-8","type":"journal-article","created":{"date-parts":[[2010,9,13]],"date-time":"2010-09-13T08:03:51Z","timestamp":1284365031000},"page":"721-727","source":"Crossref","is-referenced-by-count":47,"title":["Comparative analysis of mutation of tyrosine kinase kit in mast cells from patients with systemic mast cell activation syndrome and healthy subjects"],"prefix":"10.1007","volume":"62","author":[{"given":"Gerhard J.","family":"Molderings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Meis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich W.","family":"Kolck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Homann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Frieling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,14]]},"reference":[{"key":"474_CR1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1478-3231.2008.01839.x","volume":"29","author":"K Alfter","year":"2009","unstructured":"Alfter K, von K\u00fcgelgen I, Haenisch B et al (2009) New aspects of liver abnormalities as part of the systemic mast cell activation syndrome. Liver Int 29:181\u2013186","journal-title":"Liver Int."},{"key":"474_CR2","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2010.02.019","volume":"125","author":"I Alvarez-Twose","year":"2010","unstructured":"Alvarez-Twose I, Gonz\u00e1lez de Olano D, S\u00e1nchez-Mu\u00f1oz L et al (2010) Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms. J Allergy Clin Immunol 125:1269\u20131278","journal-title":"J. Allergy Clin. Immunol."},{"key":"474_CR3","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1182\/blood-2008-12-190934","volume":"114","author":"SR Bandi","year":"2009","unstructured":"Bandi SR, Brandts C, Rensinghoff M et al (2009) E3 ligase-defective Cbl mutants lead to a generalized mastocytosis and a myeloproliferative disease. Blood 114:4197\u20134208","journal-title":"Blood"},{"key":"474_CR4","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/jid.2009.281","volume":"130","author":"C Bodemer","year":"2010","unstructured":"Bodemer C, Hermine O, Palm\u00e9rini F et al (2010) Pediatric mastocytosis is a clonal disease associated with D(816)V and other activating c-KIT mutations. J Invest Dermatol 130:804\u2013815","journal-title":"J. Invest. Dermatol."},{"key":"474_CR5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000048188","volume":"127","author":"M Castells","year":"2002","unstructured":"Castells M, Austen KF (2002) Mastocytosis: mediator related signs and symptoms. Int Arch Allergy Immunol 127:147\u2013152","journal-title":"Int. Arch. Allergy Immunol."},{"key":"474_CR6","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1056\/NEJMc061882","volume":"355","author":"SC Chu","year":"2006","unstructured":"Chu SC, Tang JL, Li CC (2006) Dasatinib in chronic myelogenous leukemia. N Engl J Med 355:1062\u20131063","journal-title":"N Engl J. Med."},{"key":"474_CR7","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1038\/sj.onc.1207525","volume":"23","author":"A Duensing","year":"2004","unstructured":"Duensing A, Medeiros F, McConarty B et al (2004) Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs). Oncogene 23:3999\u20134006","journal-title":"Oncogene"},{"key":"474_CR8","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.leukres.2005.12.020","volume":"30","author":"A Fontalba","year":"2006","unstructured":"Fontalba A, Real PJ, Fernandez-Luna JL, Agirre X, Prosper F, Richard C (2006) Identification of c-Kit gene mutations in patients with polycythemia vera. Leuk Res 30:1325\u20131326","journal-title":"Leuk. Res."},{"key":"474_CR9","first-page":"1160","volume":"159","author":"R Foster","year":"2008","unstructured":"Foster R, Byrnes E, Meldrum C et al (2008) Association of paediatric mastocytosis with a polymorphism resulting in an amino acid substitution (M541L) in the transmembrane domain of c-KIT. Br J Dermatol 159:1160\u20131169","journal-title":"Br. J. Dermatol."},{"key":"474_CR10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2141.2001.02783.x","volume":"113","author":"R Fritsche-Polanz","year":"2001","unstructured":"Fritsche-Polanz R, Jordan JH, Feix A, Sperr WR (2001) Mutation analysis of c-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis. Br J Haematol 113:357\u2013364","journal-title":"Br. J. Haematol."},{"key":"474_CR11","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.21.120601.141025","volume":"23","author":"SJ Galli","year":"2005","unstructured":"Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M (2005) Mast cells as \"tunable\" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 23:749\u2013786","journal-title":"Annu. Rev. Immunol."},{"key":"474_CR12","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/jnci\/djj137","volume":"98","author":"A Goncalves","year":"2006","unstructured":"Goncalves A, Monges G, Yang Y (2006) Response of a KIT-positive extra-abdominal fibromatosis to imatinib mesylate and KIT genetic analysis. J Natl Cancer Inst 98:562\u2013563","journal-title":"J. Natl Cancer Inst."},{"key":"474_CR13","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.beha.2005.07.013","volume":"19","author":"J Gotlib","year":"2006","unstructured":"Gotlib J, Cross NCR, Gilliland DG (2006) Eosinophilic disorders: Molecular pathogenesis, new classification, and modern therapy. Best Pract Res Clin Haematol 19:535\u2013569","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"474_CR14","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1200\/JCO.2003.04.190","volume":"21","author":"MC Heinrich","year":"2003","unstructured":"Heinrich MC, Corless CL, Demetri GD et al (2003) Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 21:4342\u20134349","journal-title":"J. Clin. Oncol."},{"key":"474_CR15","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1200\/JCO.2006.06.2265","volume":"24","author":"MC Heinrich","year":"2006","unstructured":"Heinrich MC, Corless CL, Blanke CD et al (2006) Molecular correlates of imatinib resistance in gastrointestinal stromal tumors. J Clin Oncol 24:4764\u20134774","journal-title":"J. Clin. Oncol."},{"key":"474_CR16","doi-asserted-by":"crossref","first-page":"e2266","DOI":"10.1371\/journal.pone.0002266","volume":"3","author":"O Hermine","year":"2008","unstructured":"Hermine O, Lortholary O, Leventhal PS et al (2008) Case-control cohort study of patients\u2019 perceptions of disability in mastocytosis. PLoS ONE 3:e2266","journal-title":"PLoS ONE"},{"key":"474_CR17","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/sj.leu.2402341","volume":"16","author":"K Inokuchi","year":"2002","unstructured":"Inokuchi K, Yamaguchi H, Tarusawa M et al (2002) Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia\u2014potential clinical significance. Leukemia 16:170\u2013177","journal-title":"Leukemia"},{"key":"474_CR18","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1182\/blood-2004-06-2068","volume":"105","author":"TM Kohl","year":"2005","unstructured":"Kohl TM, Schnittger S, Ellwart JW, Hiddemann W, Spiekermann K (2005) KIT exon 8 mutations associated with core-binding factor (CBF)-acute myeloid leukemia (AML) cause hyperactivation of the receptor in response to stem cell factor. Blood 105:3319\u20133321","journal-title":"Blood"},{"key":"474_CR19","unstructured":"Kolck UW (2009) Investigations on the pathogenesis of the systemic mast cell activation syndrome and its impact on heart function. Bonn, University, medical thesis; URN:nbn:de:hbz:5N-19064; http:\/\/hss.ulb.uni-bonn.de\/2009\/1906\/1906.htm [in German]"},{"key":"474_CR20","first-page":"5","volume":"3","author":"J Lennartsson","year":"2005","unstructured":"Lennartsson J, Voytyuk O, Heiss E, Sundberg C, Sun J, Ronnstrand L (2005) c-Kit signal transduction and involvement in cancer. Cancer Ther 3:5\u201328","journal-title":"Cancer Ther."},{"key":"474_CR21","doi-asserted-by":"crossref","first-page":"10866","DOI":"10.1016\/S0021-9258(19)50098-9","volume":"267","author":"S Lev","year":"1992","unstructured":"Lev S, Yarden Y, Givol D (1992) A recombinant ectodomain of the receptor for the stem cell factor (SCF) retains ligand-induced receptor dimerization and antagonizes SCF-stimulated cellular responses. J Biol Chem 267:10866\u201310873","journal-title":"J. Biol. Chem."},{"key":"474_CR22","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1182\/blood-2009-02-205237","volume":"113","author":"KH Lim","year":"2009","unstructured":"Lim KH, Tefferi A, Lasho TL et al (2009) Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood 113:5727\u20135736","journal-title":"Blood"},{"key":"474_CR23","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.4049\/jimmunol.180.8.5466","volume":"180","author":"M Mayerhofer","year":"2008","unstructured":"Mayerhofer M, Gleixner KV, Hoelbl A et al (2008) Unique effects of KIT D816V in BaF3 cells: induction of cluster formation, histamine synthesis, and early mast cell differentiation antigens. J Immunol 180:5466\u20135476","journal-title":"J. Immunol."},{"key":"474_CR24","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1055\/s-2006-951337","volume":"131","author":"GJ Molderings","year":"2006","unstructured":"Molderings GJ, Kolck U, Scheurlen C et al (2006) Systemic mast cell disease with gastrointestinal symptoms\u2014a diagnostic questionnaire. Dtsch Med Wochenschr 131:2095\u20132100 [in German with English abstract]","journal-title":"Dtsch Med. Wochenschr."},{"key":"474_CR25","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/00365520701245744","volume":"42","author":"GJ Molderings","year":"2007","unstructured":"Molderings GJ, Kolck UW, Scheurlen C, Br\u00fcss M, Homann J, von K\u00fcgelgen I (2007) Multiple novel alterations in Kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder. Scand J Gastroenterol 42:1045\u20131053","journal-title":"Scand. J. Gastroenterol."},{"key":"474_CR26","first-page":"210","volume":"13","author":"H Nagata","year":"1996","unstructured":"Nagata H, Worobec AS, Metcalfe DD (1996) Identification of a polymorphism in the transmembrane domain of the protooncogene c-kit in healthy subjects. Exp Clin Immunogenet 13:210\u2013214","journal-title":"Exp. Clin. Immunogenet."},{"key":"474_CR27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2141.2007.06619.x","volume":"138","author":"A Orfao","year":"2007","unstructured":"Orfao A, Garcia-Montero AC, Sanchez L, Escribano L, REMA (2007) Recent advances in the understanding of mastocytosis: the role of KIT mutations. Br J Haematol 138:12\u201330","journal-title":"Br. J. Haematol."},{"key":"474_CR28","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1080\/10428190802140865","volume":"49","author":"O Ozer","year":"2008","unstructured":"Ozer O, Zhao YD, Ostler KR et al (2008) The identification and characterisation of novel KIT transcripts in aggressive mast cell malignancies and normal CD34+ cells. Leuk Lymphoma 49:1567\u20131577","journal-title":"Leuk. Lymphoma"},{"issue":"9","key":"474_CR29","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/j.1468-3083.2010.03599.x","volume":"24","author":"J Rocha","year":"2010","unstructured":"Rocha J, Luz Duarte M, Marques H et al (2010) Association of adult mastocytosis with M541L in the transmembrane domain of KIT. J Eur Acad Dermatol Venereol 24:1118\u20131119","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"474_CR30","first-page":"2215","volume":"25","author":"S Tayal","year":"2005","unstructured":"Tayal S, Classen E, Bemis L, Robinson WA (2005) C-kit expression in dedifferentiated and well-differentiated liposarcomas; immunohistochemistry and genetic analysis. Anticancer Res 25:2215\u20132220","journal-title":"Anticancer Res."},{"key":"474_CR31","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jaci.2009.10.020","volume":"125","author":"C Teodosio","year":"2010","unstructured":"Teodosio C, Garc\u00eda-Montero AC, Jara-Acevedo M et al (2010) Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes. J Allergy Clin Immunol 125:719\u2013726","journal-title":"J. Allergy Clin. Immunol."},{"key":"474_CR32","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","volume":"25","author":"P Valent","year":"2001","unstructured":"Valent P, Horny HP, Escribano L et al (2001) Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 25:603\u2013625","journal-title":"Leuk. Res."},{"key":"474_CR33","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","volume":"37","author":"P Valent","year":"2007","unstructured":"Valent P, Akin C, Escribano L et al (2007) Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 37:435\u2013453","journal-title":"Eur J Clin Invest"},{"key":"474_CR34","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.1021\/jm050231m","volume":"48","author":"J Vend\u00f4me","year":"2005","unstructured":"Vend\u00f4me J, Letard S, Martin F et al (2005) Molecular modeling of wild-type and D816V c-Kit inhibition based on ATP-competitive binding of ellipticine derivatives to tyrosine kinases. J Med Chem 48:6194\u20136201","journal-title":"J. Med. Chem."},{"key":"474_CR35","doi-asserted-by":"crossref","unstructured":"Yang Y, L\u00e9tard S, Borge L (2010) Pediatric mastocytosis-associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with KIT-phosphotransferase domain mutations. Blood 116:114\u20131123","DOI":"10.1182\/blood-2009-06-226027"},{"key":"474_CR36","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.cell.2007.05.055","volume":"130","author":"S Yuzawa","year":"2007","unstructured":"Yuzawa S, Opatowsky Y, Zhang Z, Mandiyan V, Lax I, Schlessinger J (2007) Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor. Cell 130:323\u2013334","journal-title":"Cell"}],"container-title":["Immunogenetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00251-010-0474-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00251-010-0474-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00251-010-0474-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T09:40:11Z","timestamp":1711791611000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00251-010-0474-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,14]]},"references-count":36,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["474"],"URL":"https:\/\/doi.org\/10.1007\/s00251-010-0474-8","relation":{},"ISSN":["0093-7711","1432-1211"],"issn-type":[{"value":"0093-7711","type":"print"},{"value":"1432-1211","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,14]]}}}